Analysis of Th1- and Th17-phenotypes showed that SPMS and PPMS patients had an increased frequency of IL23-receptor (IL23R)+CD4+T-cells, presumably Th17-cells [35], in blood compared to HCs (Figure 1H–I). The gene discussed is CD4; the disease is secondary progressive multiple sclerosis.